About us
Why Do We Need CINAMR?
Infectious diseases remain a major challenge in the UK and internationally, affecting patients across all age groups and settings. While infection research at Brighton and Sussex Medical School (BSMS), University Hospitals Sussex (UHSussex), and the Universities of Brighton and Sussex is thriving, we must unify efforts to maximise synergy, foster collaboration, and deliver meaningful impact for patients and communities. The Centre of Infection and Antimicrobial Research (CINAMR) has been established to bring together researchers, clinicians, innovators, policymakers and patients to create a unified, multidisciplinary approach to infection research.
A key focus of CINAMR is tackling health inequalities and underserved groups in coastal communities, which face disproportionately high infection burdens and antimicrobial resistance (AMR). By integrating research across bacterial, viral, and fungal infections, from neonates to older adults, CINAMR will maximise opportunities to convert scientific discoveries to real-world improvements.
Through collaboration, innovation, and education, CINAMR will shape the future of local infection research, delivering equitable, sustainable, and globally relevant solutions.
Vision
"Excellence, Innovation, and Equity in Infection Research"
Mission
CINAMR is committed to advancing infection research and improving patient outcomes by:
- Bridging research and clinical practice to ensure scientific discoveries translate into meaningful healthcare improvements.
- Addressing antimicrobial resistance and infection prevention through innovative, evidence-based approaches.
- Tackling health inequalities, particularly in underserved coastal communities, where infection burdens are highest.
- Driving collaboration across academia, healthcare, industry, and community to accelerate real-world impact.
- Training the next generation of infection researchers and healthcare professionals, ensuring a strong, sustainable workforce.
Our work spans laboratory science, clinical trials, implementation research, and policy development, ensuring that our infection research benefits patients and healthcare systems in the UK and globally.
The Centre’s Unique Strengths
The Centre of Infection and Antimicrobial Research (CINAMR) is uniquely positioned to lead transformative infection research by integrating expertise across multiple disciplines and focusing on real-world healthcare challenges.
Addressing Health Inequalities in Coastal Communities
- Coastal regions, including the Southeast of England, face high infection burdens and patients disproportionately likely to have worse outcomes from infection, particularly among older adults, LGBTQIA+, women, people who inject drugs, and asylum seekers.
- By embedding equity and inclusion at its core, CINAMR ensures that research is locally relevant and globally translatable.
Leading Antimicrobial Resistance (AMR) and Infection Prevention Research
- AMR is one of the greatest threats to health. CINAMR drives cutting-edge research in the development of new treatments, infection control, and antimicrobial stewardship.
- The integration of the Sussex AMR Network strengthens collaboration across microbiology, epidemiology, public health, anthropology, and policy.
Translational Research: From Bench to Bedside
Strategic Global Collaborations
- CINAMR collaborates with international research institutions, industry partners, and policy organisations to address global infection challenges.
- Its geographical position near London and Gatwick Airport provides a unique opportunity to study infection risks linked to international travel and emerging global health threats.
A Commitment to Sustainability & Innovation
- CINAMR integrates sustainable infection prevention strategies, ensuring research aligns with environmental responsibility.
- By leveraging health economics and digital innovation, CINAMR maximises the cost-effectiveness and long-term impact of its work.
By combining academic excellence, clinical expertise, and societal impact, CINAMR is establishing itself as a leading hub for infection research, shaping the future of infection prevention and treatment in the UK and beyond.